Skip to main content
Erschienen in: Documenta Ophthalmologica 3/2014

01.12.2014 | Original Research Article

Ten-year follow-up of two unrelated patients with Müller cell sheen dystrophy and first report of successful vitrectomy

verfasst von: Agnes B. Renner, Viola Radeck, Ulrich Kellner, Herbert Jägle, Horst Helbig

Erschienen in: Documenta Ophthalmologica | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To describe clinical characteristics of Müller cell sheen dystrophy (MCSD) in two unrelated patients followed for 10 years.

Methods

Best-corrected visual acuity (BCVA), kinetic perimetry, biomicroscopy, ophthalmoscopy, fundus photography, fluorescein angiography, fundus autofluorescence, near-infrared reflectance, optical coherence tomography (OCT), and electroretinography (ERG).

Results

Case 1: A 61-year-old woman showed internal limiting membrane (ILM) folds at the posterior pole (OU), and cystoid macular edema (CME) in OD. During follow-up, BCVA decreased from 0.2 to 0.06 (OD) and from 0.7 to hand movements (OS). Fundus presented fluctuant CME and subretinal fluid, and an increase in ILM folds and intraretinal schisis cavities. ERG was negative in OD and initially normal in OS. Case 2: A 60-year-old man was first diagnosed with epiretinal membrane before MCSD with ILM folds was detected. OCT showed schisis cavities in all retinal layers. After vitrectomy with ILM peeling in OD because of visual loss and massive CME, BCVA recovered from 0.05 to 0.4. BCVA in OS remained at 0.6. OD developed negative ERG.

Conclusions

MCSD presents with late onset, ILM folds, intraretinal schisis cavities, and negative ERG. Visual loss is accompanied by CME and subretinal fluid. Vitrectomy with ILM peeling led to BCVA increase and anatomic improvement.
Literatur
1.
Zurück zum Zitat Dalma A et al. (1991) Invest Ophthalmol Vis Sci 32. ARVO Abstract 2738 Dalma A et al. (1991) Invest Ophthalmol Vis Sci 32. ARVO Abstract 2738
2.
Zurück zum Zitat Polk TD, Gass JDM, Green WR, Novak MA, Johnson MW (1997) Familial internal limiting membrane dystrophy. A new sheen retinal dystrophy. Arch Ophthalmol 115:878–885PubMedCrossRef Polk TD, Gass JDM, Green WR, Novak MA, Johnson MW (1997) Familial internal limiting membrane dystrophy. A new sheen retinal dystrophy. Arch Ophthalmol 115:878–885PubMedCrossRef
3.
Zurück zum Zitat Kellner U, Kraus H, Heimann H, Helbig H, Bornfeld N, Foerster M (1998) Electrophysiological evaluation of visual loss in Müller cell sheen dystrophy. Br J Ophthalmol 82:650–654PubMedCentralPubMedCrossRef Kellner U, Kraus H, Heimann H, Helbig H, Bornfeld N, Foerster M (1998) Electrophysiological evaluation of visual loss in Müller cell sheen dystrophy. Br J Ophthalmol 82:650–654PubMedCentralPubMedCrossRef
4.
Zurück zum Zitat Franco-Cardenas V et al. (2013) Invest Ophthalmol Vis Sci 54. ARVO E-Abstract 5921 Franco-Cardenas V et al. (2013) Invest Ophthalmol Vis Sci 54. ARVO E-Abstract 5921
5.
Zurück zum Zitat Renner AB, Tillack H, Kraus H, Kohl S, Wissinger B, Mohr N, Weber BHF, Kellner U, Foerster M (2004) Morphology and functional characteristics in adult vitelliform macular dystrophy. Retina 24:929–939PubMedCrossRef Renner AB, Tillack H, Kraus H, Kohl S, Wissinger B, Mohr N, Weber BHF, Kellner U, Foerster M (2004) Morphology and functional characteristics in adult vitelliform macular dystrophy. Retina 24:929–939PubMedCrossRef
6.
Zurück zum Zitat Renner AB, Walter A, Fiebig BS, Jägle H (2012) Gyrate atrophy: clinical and genetic findings in a female without arginine-restricted diet during her first 39 years of life and report of a new OAT gene mutation. Doc Ophthalmol 125:81–89PubMedCrossRef Renner AB, Walter A, Fiebig BS, Jägle H (2012) Gyrate atrophy: clinical and genetic findings in a female without arginine-restricted diet during her first 39 years of life and report of a new OAT gene mutation. Doc Ophthalmol 125:81–89PubMedCrossRef
7.
Zurück zum Zitat Marmor MF, Fulton AB, Holder GE, Miyake Y, Brigell M, Bach M (2009) ISCEV Standard for full-field clinical electroretinography (2008 update). Doc Ophthalmol 118:69–77PubMedCrossRef Marmor MF, Fulton AB, Holder GE, Miyake Y, Brigell M, Bach M (2009) ISCEV Standard for full-field clinical electroretinography (2008 update). Doc Ophthalmol 118:69–77PubMedCrossRef
8.
Zurück zum Zitat Fishman GA, Gilbert LD, Fiscella RG, Kimura AE, Jampol LM (1989) Acetazolamide for treatment of chronic macular edema in retinitis pigmentosa. Arch Ophthalmol 107:1445–1452PubMedCrossRef Fishman GA, Gilbert LD, Fiscella RG, Kimura AE, Jampol LM (1989) Acetazolamide for treatment of chronic macular edema in retinitis pigmentosa. Arch Ophthalmol 107:1445–1452PubMedCrossRef
9.
Zurück zum Zitat Grover S, Fishman GA, Fiscella RG, Adelman AE (1997) Efficacy of dorzolamide hydrochloride in the management of chronic cystoid macular edema in patients with retinitis pigmentosa. Retina 17:222–231PubMedCrossRef Grover S, Fishman GA, Fiscella RG, Adelman AE (1997) Efficacy of dorzolamide hydrochloride in the management of chronic cystoid macular edema in patients with retinitis pigmentosa. Retina 17:222–231PubMedCrossRef
10.
11.
Zurück zum Zitat Shen W, Fruttiger M, Zhu L, Chung SH, Barnett NL, Kirk JK, Lee S, Coorey NJ, Killingsworth M, Sherman LS, Gillies MC (2012) Conditional Müller cell ablation causes independent neuronal and vascular pathologies in a novel transgenic model. J Neurosci 32:15715–15727PubMedCentralPubMedCrossRef Shen W, Fruttiger M, Zhu L, Chung SH, Barnett NL, Kirk JK, Lee S, Coorey NJ, Killingsworth M, Sherman LS, Gillies MC (2012) Conditional Müller cell ablation causes independent neuronal and vascular pathologies in a novel transgenic model. J Neurosci 32:15715–15727PubMedCentralPubMedCrossRef
12.
Zurück zum Zitat Tout S, Chan-Ling T, Hollander H, Stone J (1993) The role of Müller cells in the formation of the blood-retinal barrier. Neuroscience 55:291–301PubMedCrossRef Tout S, Chan-Ling T, Hollander H, Stone J (1993) The role of Müller cells in the formation of the blood-retinal barrier. Neuroscience 55:291–301PubMedCrossRef
Metadaten
Titel
Ten-year follow-up of two unrelated patients with Müller cell sheen dystrophy and first report of successful vitrectomy
verfasst von
Agnes B. Renner
Viola Radeck
Ulrich Kellner
Herbert Jägle
Horst Helbig
Publikationsdatum
01.12.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Documenta Ophthalmologica / Ausgabe 3/2014
Print ISSN: 0012-4486
Elektronische ISSN: 1573-2622
DOI
https://doi.org/10.1007/s10633-014-9463-9

Weitere Artikel der Ausgabe 3/2014

Documenta Ophthalmologica 3/2014 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.